Cartesian Therapeutics Announces New Employment Inducement Grants
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapies for the treatment of autoimmune diseases, today announced the ...
Hosted on MSN1d
GSK (GSK) Tops Q4 Earnings and Revenue Estimates
GSK (GSK) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.72 per share a year ago. These figures are ...
El Mundo on MSN1d
These are the 11 new best-selling drugs that will transform Medicine in 2025
The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...
IPO Roundup: Titan America, Aureus Greenway and more
Stay updated on the latest financial news and upcoming IPOs/SPACs with this article covering Titan America, Smithfield Foods, ...
Genfit SA (GNFT) Receives a Rating Update from a Top Analyst
In a report released on January 30, Thomas Smith from Leerink Partners reiterated a Buy rating on Genfit SA (GNFT – Research Report). The ...